Form 4 for EW Edwards Lifesciences
Accepted 2024-02-08 00:00:00 ET · period of report 2024-02-08 · accession 0001225208-24-001791 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-08 | 2024-02-08 | EW | STONE HEISZ LESLIE | Dir | S - Sale+OE | $86.45 | -7,056 | 27.0K | -21% | -$610.0K |
| D | 2024-02-08 | 2024-02-08 | EW | STONE HEISZ LESLIE | Dir | M - OptEx | $36.86 | +7,056 | 34.0K | +26% | +$260.1K |
| D | 2024-02-08 | 2024-02-08 | EW | STONE HEISZ LESLIE | Dir | M - OptEx | $0.00 | -7,056 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-08 | S | D | 7,056 | $86.45 | 26,980 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-08 | M | A | 7,056 | $36.86 | 34,036 | D | — | — | |
| 3 | Derivative | Director Stock Option (Right to Acquire) | 2024-02-08 | M | D | 7,056 | $0.00 | 0 | D | $36.86 · 2017-05-12 to 2024-05-11 | 7,056 Common Stock |